UAE Pharmaceutical Market By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2028
The UAE pharmaceutical market is anticipated to register impressive growth in the forecast period (2024-2028). This growth is attributed to the expanding healthcare industry and the rising demand for efficient pharmaceutical products. Other factors such as growing government initiatives, rising incidences of diseases in the country, increased drug approvals by regulatory bodies, and others are expected to bolster the growth of the UAE pharmaceutical market. According to the International Diabetes Federation, in 2021, out of thousands, about 990 Emiratis were suffering from diabetes. Additionally, the growing research and development activities in the pharmaceutical industry are projected to augment the growth of the UAE pharmaceutical market in the forthcoming years.
Furthermore, the growing government support, such as the encouragement by the Ministry of Health and Prevention for international pharmaceutical companies to transfer their production lines to the UAE, is another factor strengthening the UAE pharmaceutical market.
Growing Government Initiatives:
The rising number of initiatives by the United Arab Emirates government for the advancement of the pharmaceutical industry is expected to fuel the market's growth. The UAE pharmaceutical market is targeted by initiatives such as the Dubai Industrial Strategy 2030 and the Abu Dhabi Vision 2030 due to its potential for future growth, export potential, and medium- to long-term economic impact. Additionally, the increasing investments by the government in the research and development of pharmaceutical and therapeutic products are expected to drive the market's growth in the coming years.
Rising Occurrences of Diseases:
The growing prevalence of various diseases such as cancer, diabetes, cardiovascular disorders, respiratory problems, renal disorders, among others, in the country, requires effective treatment and is expected to drive the growth of the UAE pharmaceutical market during the forecast period. For instance, according to the Global Cancer Observatory, in 2020, about 4,807 new cases of cancer were reported in the UAE. Out of these, 1,030 were breast cancer, 510 were colorectal cancer, 405 were thyroid cancer, 272 were leukemia, 270 were prostate cancer, and 2,380 were other types of cancers. Furthermore, the increasing disease burden has led to a surge in the demand for pharmaceutical products, which is expected to bolster the market's growth.
Market Segmentation
The UAE pharmaceutical market is segmented by drug type, product type, application, distribution channel, company, and region. Based on drug type, the market is differentiated between generic drugs and branded drugs. Based on product type, the market is divided between prescription drugs and over the counter drugs. Based on application, the market is fragmented into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, and others. Based on distribution channel, the market is bifurcated into retail pharmacy, hospital pharmacy, and e-pharmacy. Based on region, the market is divided among Dubai region, Sharjah region, Abu Dhabi region and the rest of the UAE.
Company Profile
Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma, Pfizer UAE, Johnson & Johnson Middle East FZ-LLC, among others are some of the major market players in the UAE pharmaceutical market.
Report Scope:
In this report, UAE pharmaceutical market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in UAE pharmaceutical market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Furthermore, the growing government support, such as the encouragement by the Ministry of Health and Prevention for international pharmaceutical companies to transfer their production lines to the UAE, is another factor strengthening the UAE pharmaceutical market.
Growing Government Initiatives:
The rising number of initiatives by the United Arab Emirates government for the advancement of the pharmaceutical industry is expected to fuel the market's growth. The UAE pharmaceutical market is targeted by initiatives such as the Dubai Industrial Strategy 2030 and the Abu Dhabi Vision 2030 due to its potential for future growth, export potential, and medium- to long-term economic impact. Additionally, the increasing investments by the government in the research and development of pharmaceutical and therapeutic products are expected to drive the market's growth in the coming years.
Rising Occurrences of Diseases:
The growing prevalence of various diseases such as cancer, diabetes, cardiovascular disorders, respiratory problems, renal disorders, among others, in the country, requires effective treatment and is expected to drive the growth of the UAE pharmaceutical market during the forecast period. For instance, according to the Global Cancer Observatory, in 2020, about 4,807 new cases of cancer were reported in the UAE. Out of these, 1,030 were breast cancer, 510 were colorectal cancer, 405 were thyroid cancer, 272 were leukemia, 270 were prostate cancer, and 2,380 were other types of cancers. Furthermore, the increasing disease burden has led to a surge in the demand for pharmaceutical products, which is expected to bolster the market's growth.
Market Segmentation
The UAE pharmaceutical market is segmented by drug type, product type, application, distribution channel, company, and region. Based on drug type, the market is differentiated between generic drugs and branded drugs. Based on product type, the market is divided between prescription drugs and over the counter drugs. Based on application, the market is fragmented into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, and others. Based on distribution channel, the market is bifurcated into retail pharmacy, hospital pharmacy, and e-pharmacy. Based on region, the market is divided among Dubai region, Sharjah region, Abu Dhabi region and the rest of the UAE.
Company Profile
Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma, Pfizer UAE, Johnson & Johnson Middle East FZ-LLC, among others are some of the major market players in the UAE pharmaceutical market.
Report Scope:
In this report, UAE pharmaceutical market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- UAE Pharmaceutical Market, By Drug Type:
- Generic Drugs
- Branded Drugs
- UAE Pharmaceutical Market, By Product Type:
- Prescription Drugs
- Over the Counter Drugs
- UAE Pharmaceutical Market, By Application:
- Cardiovascular
- Musculoskeletal
- Oncology
- Anti-infective
- Metabolic Disorder
- Others
- UAE Pharmaceutical Market, By Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- E-Pharmacy
- UAE Pharmaceutical Market, By Region:
- Dubai Region
- Sharjah Region
- Abu Dhabi Region
- Rest of UAE
Company Profiles: Detailed analysis of the major companies present in UAE pharmaceutical market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE PHARMACEUTICAL MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. UAE PHARMACEUTICAL MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)
6.2.2. By Product Type (Prescription Drugs v/s Over the Counter Drugs)
6.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2022)
6.3. Product Market Map
7. UAE GENERIC DRUGS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By Distribution Channel
8. UAE BRANDED DRUGS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By Distribution Channel
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
11. POLICY & REGULATORY LANDSCAPE
12. UAE ECONOMIC PROFILE
13. COMPETITIVE LANDSCAPE
13.1. Competition Outlook
13.2. Company Profiles
13.2.1. Julphar Gulf Pharmaceutical Industries
13.2.2. Bayer Consumer Health
13.2.3. Lifepharma FZE
13.2.4. Niner Pharmaceuticals LLC
13.2.5. GlaxoSmithKline & Neopharma
13.2.6. Pfizer UAE
13.2.7. Johnson & Johnson Middle East FZ-LLC
14. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE PHARMACEUTICAL MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. UAE PHARMACEUTICAL MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)
6.2.2. By Product Type (Prescription Drugs v/s Over the Counter Drugs)
6.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2022)
6.3. Product Market Map
7. UAE GENERIC DRUGS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By Distribution Channel
8. UAE BRANDED DRUGS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By Distribution Channel
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
11. POLICY & REGULATORY LANDSCAPE
12. UAE ECONOMIC PROFILE
13. COMPETITIVE LANDSCAPE
13.1. Competition Outlook
13.2. Company Profiles
13.2.1. Julphar Gulf Pharmaceutical Industries
13.2.2. Bayer Consumer Health
13.2.3. Lifepharma FZE
13.2.4. Niner Pharmaceuticals LLC
13.2.5. GlaxoSmithKline & Neopharma
13.2.6. Pfizer UAE
13.2.7. Johnson & Johnson Middle East FZ-LLC
14. STRATEGIC RECOMMENDATIONS
